MacNealy Hoover Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
MacNealy Hoover Investment Management's PFE Position: Q3 2019 in Review
MacNealy Hoover Investment Management reduced its Pfizer (PFE) stake by 1.6% in Q3 2019, selling an estimated $20.9K and leaving 34,572 shares worth $1.18M. The position accounts for 0.95% of the portfolio, ranked #39.
MacNealy Hoover Investment Management first reported a position in PFE in Q4 2013 and has held it in 24 quarters since. The position peaked at $1.53M in Q3 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- MacNealy Hoover Investment Management held 34,572 shares of Pfizer worth $1.18M as of Q3 2019.
- MacNealy Hoover Investment Management sold 574 Pfizer shares in Q3 2019, an estimated $20.9K.
- Pfizer made up 0.95% of MacNealy Hoover Investment Management's portfolio in Q3 2019, its #39 holding.
- MacNealy Hoover Investment Management first reported a position in Pfizer in Q4 2013 and has held it in 24 quarters since.
- MacNealy Hoover Investment Management's Pfizer position peaked at $1.53M in Q3 2018.
- 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on MacNealy Hoover Investment Management's 13F filing for Q3 2019, filed 1 Oct 2019.